Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 7
2012 4
2013 2
2014 5
2015 6
2016 13
2017 12
2018 10
2019 12
2020 13
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean shih chi yu (4 results)?
HLA Association with Drug-Induced Adverse Reactions.
Fan WL, Shiao MS, Hui RC, Su SC, Wang CW, Chang YC, Chung WH. Fan WL, et al. Among authors: su sc. J Immunol Res. 2017;2017:3186328. doi: 10.1155/2017/3186328. Epub 2017 Nov 23. J Immunol Res. 2017. PMID: 29333460 Free PMC article. Review.
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.
Wang CW, Yang LY, Chen CB, Ho HC, Hung SI, Yang CH, Chang CJ, Su SC, Hui RC, Chin SW, Huang LF, Lin YY, Chang WY, Fan WL, Yang CY, Ho JC, Chang YC, Lu CW, Chung WH; the Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium. Wang CW, et al. Among authors: su sc. J Clin Invest. 2018 Mar 1;128(3):985-996. doi: 10.1172/JCI93349. Epub 2018 Feb 5. J Clin Invest. 2018. PMID: 29400697 Free PMC article. Clinical Trial.
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.
Chen CB, Wu MY, Ng CY, Lu CW, Wu J, Kao PH, Yang CK, Peng MT, Huang CY, Chang WC, Hui RC, Yang CH, Yang SF, Chung WH, Su SC. Chen CB, et al. Among authors: su sc. Cancer Manag Res. 2018 May 17;10:1259-1273. doi: 10.2147/CMAR.S163391. eCollection 2018. Cancer Manag Res. 2018. PMID: 29844705 Free PMC article. Review.
Pathogenic Variants in CEP85L Cause Sporadic and Familial Posterior Predominant Lissencephaly.
Tsai MH, Muir AM, Wang WJ, Kang YN, Yang KC, Chao NH, Wu MF, Chang YC, Porter BE, Jansen LA, Sebire G, Deconinck N, Fan WL, Su SC, Chung WH, Almanza Fuerte EP, Mehaffey MG; University of Washington Center for Mendelian Genomics, Ng CC, Chan CK, Lim KS, Leventer RJ, Lockhart PJ, Riney K, Damiano JA, Hildebrand MS, Mirzaa GM, Dobyns WB, Berkovic SF, Scheffer IE, Tsai JW, Mefford HC. Tsai MH, et al. Among authors: su sc. Neuron. 2020 Apr 22;106(2):237-245.e8. doi: 10.1016/j.neuron.2020.01.027. Epub 2020 Feb 24. Neuron. 2020. PMID: 32097630
Cancer metastasis: Mechanisms of inhibition by melatonin.
Su SC, Hsieh MJ, Yang WE, Chung WH, Reiter RJ, Yang SF. Su SC, et al. J Pineal Res. 2017 Jan;62(1). doi: 10.1111/jpi.12370. Epub 2016 Nov 25. J Pineal Res. 2017. PMID: 27706852 Review.
Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis.
Chen CH, Chen CB, Chang CJ, Lin YJ, Wang CW, Chi CC, Lu CW, Chen WT, Pan RY, Su SC, Hsu LA, Chang YC, Yu KH, Wu YJ, Lin KM, Hung SI, Chen SM, Chung WH. Chen CH, et al. Among authors: su sc. Clin Pharmacol Ther. 2019 Aug;106(2):391-401. doi: 10.1002/cpt.1377. Epub 2019 Mar 20. Clin Pharmacol Ther. 2019. PMID: 30690722
New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence.
Lu KH, Lin CW, Hsieh YH, Su SC, Reiter RJ, Yang SF. Lu KH, et al. Among authors: su sc. Cancer Metastasis Rev. 2020 Mar;39(1):303-320. doi: 10.1007/s10555-020-09845-2. Cancer Metastasis Rev. 2020. PMID: 32086631 Review.
The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.
Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Cheung CM, Huang JW, Ji C, Cheng B, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Huang YH, Lu CW, Yang CY, Lin YT, Chi MH, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Fan WL, Hung SI, Chung WH; Asian Severe Cutaneous Adverse Reaction Consortium. Wang YH, et al. Among authors: su sc. Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9. Clin Pharmacol Ther. 2019. PMID: 29569740
Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.
Wu IW, Gao SS, Chou HC, Yang HY, Chang LC, Kuo YL, Dinh MCV, Chung WH, Yang CW, Lai HC, Hsieh WP, Su SC. Wu IW, et al. Among authors: su sc. Theranostics. 2020 Apr 6;10(12):5398-5411. doi: 10.7150/thno.41725. eCollection 2020. Theranostics. 2020. PMID: 32373220 Free PMC article.
Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study.
Wu IW, Lin CY, Chang LC, Lee CC, Chiu CY, Hsu HJ, Sun CY, Chen YC, Kuo YL, Yang CW, Gao SS, Hsieh WP, Chung WH, Lai HC, Su SC. Wu IW, et al. Among authors: su sc. Int J Biol Sci. 2020 Jan 1;16(3):420-434. doi: 10.7150/ijbs.37421. eCollection 2020. Int J Biol Sci. 2020. PMID: 32015679 Free PMC article.
82 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback